Clinical Trial Update: A Pilot Study of MONOtherapy of DOlutegravir in HIV-1 Virologically Suppressed Patients [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 pilot study evaluating dolutegravir monotherapy in HIV-1 virologically suppressed patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Tivicay (dolutegravir)

Snippet

Sponsor: Calmy Alexandra | Conditions: Human Immunodeficiency Virus, Dolutegravir | Phase 2 | Status: COMPLETED